Direct UV Spectrophotometry and HPLC determination of triton X-100 in split virus influenza vaccine

Journal of AOAC International

Volumn 99, Issue 2, 2016, Pages 396-400

  Pavlović, Bojana ^a   Cvijetić, Nataša ^a   Dragačević, Luka ^a   Ivković, Branka ^b   Vujić, Zorica ^b   Kuntić, Vesna ^b  

^a and Sera   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

METHANOL; NONIONIC SURFACTANTS; SPECTROPHOTOMETRY; SURFACE ACTIVE AGENTS; ULTRAVIOLET SPECTROPHOTOMETERS; VIRUSES;

CHROMATOGRAPHIC SYSTEMS; DETECTION AND QUANTIFICATIONS; INFLUENZA VACCINES; RESIDUAL AMOUNTS; SENSITIVE METHOD; TRITON X-100; UV SPECTROPHOTOMETRY; VIRUS PARTICLES;

VACCINES;

INFLUENZA VACCINE; OCTOXINOL;

CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAVIOLET SPECTROPHOTOMETRY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; INFLUENZA VACCINES; OCTOXYNOL; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 84964241009     PISSN: 10603271     EISSN: None     Source Type: Journal    
DOI: 10.5740/jaoacint.15-0201     Document Type: Article

References (19)

1. Lina, B., Fletcher, M.A., Valette, M., Saliou, P., & Aymard, M. (2000) Biologicals 28, 95-103. doi:10.1006/biol.2000.0245
2. About influenza vaccine, http://www.ifpma.org/resources/influenza-vaccines/influenza-vaccines/about-influenza-vaccine. html
3. Dayeh, V.R., Chow, S.L., Schirmer, K., Lynn, D.H., & Bols, N.C. (2004) Ecotoxicol. Environ. Saf. 57, 375-382. doi:10.1016/S0147-6513(03)00083-6
4. Maire, M.L., Champeil, P., & Moller, J.V. (2000) Biochim. Biophys. Acta 1508, 86-111. doi:10.1016/S0304-4157(00)00010-1
5. Holloway, P.W. (1973) Anal. Biochem. 53, 304-308. doi:10.1016/0003-2697(73)90436-3
6. Strancar, A., Raspor, P., Schwinn, H., Schötz, R., & Josic, D.J. (1994) J. Chromatogr. A 658, 475-481. doi:10.1016/0021-9673(94)80038-3
7. Components of seasonal influenza vaccines 2013/14, http://www.vaccinesafety.edu/components-Influenza.htm
8. Harma, H., Laakso, S., Pihlasalo, S., Hanninen, P., Faure, B., Rana, S., & Bergstrom, L. (2010) Nanoscale 2, 69-71. doi:10.1039/B9NR00172G
9. Xiaoyu, L., Aifang, L., Baohui, Z., Chaokun, Q., & Hongmin, R. (2009) Chem. Cent. J. 3, 7. http://dx. doi:10.1186/1752-153X-3-7
10. Norton, D., & Shamsi, S.A. (2004) Electrophoresis 25, 586-593. doi:10.1002/elps.200305682
11. Karlsson, G., Hinz, A., Henriksson, E., & Winge, S. (2002) J. Chromatogr. A 946, 163-168. doi:10.1016/S0021-9673(01)01565-5
12. Heinig, K., & Vogt, C. (1997) Fresenius J. Anal. Chem. 359, 202-206. doi:10.1007/s002160050560
13. Dong, J., Pan, R., Fan, Y., Lin, X., & Zhang, Y. (2011) J. Pharm. Anal. 31, 2174-2175
14. Medvedovici, A., David, V., Tache, F., David, F., & Sandra, P. (2001) Anal. Lett. 34, 1477-1486. doi:10.1081/AL-100104921
15. Terada, H., Seki, H., Yamamoto, K., & Kametani, F. (1985) Anal. Biochem. 149, 501-506. doi:10.1016/0003-2697(85)90605-0
16. Garewal, H.S. (1973) Anal. Biochem. 54, 319-324. doi:10.1016/0003-2697(73)90359-X
17. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Expert Working Group, ICH Harmonised Tripartite Guideline. Validation of analytical procedures: Text and methodology ICH/Q2(R1). www.ich.org/ICH./Guidelines/Q2-R1
18. Influenza, http://www.who.int/biologicals/publications/trs/areas/vaccines/influenza/en/
19. European Directorate for the Quality of Medicines & HealthCare. (2012) European Pharmacopoeia 7th Ed., 788-790